BCIQ Profiles

Company Profile Report

Tiny taxanes

How NanOlogy's particle production technology created submicron chemotherapy

NanOlogy LLC is using submicron particle production technology to rework chemotherapeutics into stable nano-sized particles and deliver them directly to disease sites. The technology could increase the efficacy and reduce the side effects associated with systemic administration.

Formed in 2015, NanOlogy pooled expertise from DFB Pharmaceuticals LLC, CritiTech Inc. and US Biotest Inc. and then licensed the exclusive rights for CritiTech’s

Read the full 616 word article

How to gain access

Continue reading with a
two-week free trial.